DiaMonTech AG logo

DiaMonTech AG

Say goodbye to finger pricking!

28 employees · est. 2015 · Berlin, Germany

VS
MELLIsim logo

MELLIsim

Diabetes care for Type 2

1 employees · est. 2019 · Villejuif, France

DiaMonTech AG is the older company (2015 vs 2019); DiaMonTech AG is the larger of the two.

Side-by-Side Comparison

DiaMonTech AG MELLIsim
Founded
2015 older 2019
Headquarters
Berlin, Germany Villejuif, France
Employees
28 larger 1
Industry
Biotechnology, Health Care, Sports Health Care, Medical Devices
Funding Stage
Non Equity Assistance Not tracked yet
Total Funding
$18.20M Not tracked yet
Funding Rounds
8 Not tracked yet
Services
Development of non-invasive glucose monitoring devices, Integration of photothermal spectroscopy in medical technology, Mobile medical product design and miniaturization, Predictive data modeling for health applications, Biomedical device regulatory and certification processes Not tracked yet
Target Customers
Individuals with Diabetes, Healthcare Providers and Professionals, Health-conscious Consumers, Insurance Companies, Smartwatch and Wearable Technology Companies Not tracked yet
Taxonomy
Non-Invasive Technology, Blood Glucose Measurement, Diabetes Management, Laser Technology, Healthcare Innovation, MedTech Startup, Glucose Monitoring, Patient-Friendly Design, Precision Health, Diabetes Care Solutions, Sensor Technology, HealthTech, Infrared Technology, Pain-Free Testing Medical Technology, Wearable Devices, Diabetes Care, Biosensors, Continuous Glucose Monitoring, Healthcare Innovation, Clinical Trials, FDA Approval, CE Mark, MedTech Start-up, Investment Opportunity, Global Health, Digital Health, Patient-Centric Care
Website
diamontech.de mellisim.com
DiaMonTech AG logo

About DiaMonTech AG

DiaMonTech AG, a breakthrough player in the Biotechnology and Health Care industries, is making strides from its headquarters in Germany. Founded in 2015, the company has garnered attention for its innovative medical device that measures blood glucose levels non-invasively. With the slogan "Say good...

MELLIsim logo

About MELLIsim

MELLIsim is an innovative health care startup founded in 2019 with the aim of addressing the unmet needs of Type 2 Diabetic (T2D) patients through its revolutionary solution, MELLIsense CGM (Continuous Glucose Monitoring). The company has collaborated with ITODYS, a leading electrochemical biosensor...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at DiaMonTech AG and MELLIsim — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at DiaMonTech AG and MELLIsim — by email.

Frequently Asked Questions

DiaMonTech AG — Say goodbye to finger pricking!. MELLIsim — Diabetes care for Type 2. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
DiaMonTech AG has raised $18.20M while MELLIsim has raised undisclosed funding.
DiaMonTech AG and MELLIsim operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare DiaMonTech AG with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy